16. Cervix cancer - The GEC-ESTRO Handbook of Brachytherapy

Cervix cancer

30

THE GEC ESTRO HANDBOOK OF BRACHYTHERAPY | Part II Clinical Practice Version 1 - 01/09/2023

Figure 30. EMBRACE-I actuarial cumulative incidence (substudy) for the risk of vaginal stenosis G≥2 in relation to PIBS point (+/- 2) doses and vaginal reference length (compare figure 19) (Reprinted from Radiother. Oncol., 168, Westerveld H, Kirchheiner K, Nout RA, et al., Dose-effect relationship between vaginal dose points and vaginal stenosis in cervical cancer: An EMBRACE-I sub-study, 8-15, 2022, with permission from Elsevier).